Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)

Sponsored by University Hospitals of Cleveland

Phase Quota
Phase N/A

Uroxatral (alfuzosin) may not only help BPH symptoms but may also improve sexual function in males with BPH and ED.

Study Start Date: November 2005

Estimated Completion Date: Not specified

Specialties: Internal Medicine: Nephrology/Urology Nursing: Nephrology/Urology Urology: Erectile Dysfunction,Prostate Family Medicine: Men`s Health


  • Drug: Alfuzosin 10 mg

Inclusion criteria

  • Males 45-75 years of age
  • Confirmed diagnosis of BPH/lower urinary tract symptoms (LUTS) and ED
  • Men with steady partner and who agree to attempt sex once a week

Exclusion criteria

  • Prostate cancer
  • Prostatitis
  • Penile disease
  • Cardiac co-morbidity
  • Pre-existing co-morbid conditions
  • History of sensitivity to the drug or similar drugs
  • Enrollment in another clinical trial
  • Impaired hepatic function
  • Impaired renal function
  • Mental conditions rendering subject unable to understand the study
  • Subjects not likely to comply with protocol

Study Locations And Contact Information

  • University Hospitals of Cleveland, Cleveland Ohio
    Contact: Ann M Serenko, MS, RN 216-844-3515
  • University Hospitals of Cleveland, Cleveland Ohio
    Contact: Allen D Seftel, MD 216-844-7728

Feature this Clinical Trial

Get your trial in front of 1000s of physicians and patients.
Visit to find out how you can feature this clinical trial.